Biogen Inc (NASDAQ:BIIB)

429.87
Delayed Data
As of Mar 27
 +0.94 / +0.22%
Today’s Change
272.02
Today|||52-Week Range
480.18
+26.64%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Biogen have a median target of 499.00, with a high estimate of 554.00 and a low estimate of 350.00. The median estimate represents a +16.08% increase from the last price of 429.87.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Biogen. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.93
Sales
$2.7B
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.86%
 
 
 
 
 
 
Growthannually 23.13%
 
 
 
 
 
 

Sales

Growthquarterly 0.76%
 
 
 
 
 
 
Growthannually 15.54%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account